PARAMETER GROUP I GROUP II  GROUP III GROUP IV
HEMOGLOBIN( g/dl) 14.7±1.92 *9.19±1.54 13.34±1.30 **9.44±1.81
IRON (µ/dl) 93±30 *58±19 *114.79±18.8 **68.52±19.63
TIBC (µ/dl) 337±56 *362±64 318.87±73.14 315.12±56.33
TRANSFERRIN SATURATION % 28±9.3 *16.74±6.29 *38.19±11.50 **22.24±7.65
FERRITIN (ng/ml) 55.5±22 *17±4.3 *103.67±50.09 **37.92±23.91
TRANSFERRIN (ng/ml) 308±22 *339±18 *348.61±24.93 350.08±29.32
INSULIN (µU/ml) 15.23±2.67 *8.67±2.67 *24.98±21.35 **19.09±12.37
HbA1C (%) 5.72±0.63 5.17±1.06 *7.85±2.24 **6.46±2.07
FASTING BLOOD SUGAR (mg/dl) 84.3±8.75 *69.91±11.84 *159.53±87.63 **120.9±31.30
HOMA IR 1.81±0.66 1.68±0.46 *11.6±10.46 **5.95±5.13
HOMA B 172.40±79 *48.52±16 *58.38±45.43 55.49±34.09
INTERLUKIN-6 (ng/ml) 4.5±3.5 6.54±4.6 3.36±2.66 **19.30±7.96
TUMOR NECROSIS FACTOR ALPHA (ng/ml) 10.5±5.39 14.28±4.7 *29.06±8.90 **24.33±19.89
*TOTAL ANTIOXIDATION CAPACITY (mMol/L) 7.38±2.4 *4.01±1.13 *3.43±0.89 3.78±1.21
MITOCHONDRIAL
OXIDATIVE CAPACITY
( nMol/min/ml)
465±187 *158±65 *204±63 179±70
Data calculated as mean ± SD
Group I: Controls
Group II: IDA
Group III: T2DM without IDA
Group IV: T2DM with IDA
*: P<0.05(significant) Group II and Group III as compared with Group I
**: P<0.05(significant) Group IV as compared with Group III
Table 2: Biochemical characteristics of study samples.